The Global Cardiovascular Risk Consortium
The Global Cardiovascular Risk Consortium (GCVRC) brings together harmonized individual-level data from currently more than 2 million (anticipated: approximately 3 million) individuals across 133 cohorts, 40 countries, and 6 continents, with recruitment ongoing. The GCVRC examines the impact of classical cardiovascular
| Condition(s) | All-cause Mortality, Cardiovascular Disease |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The Global Cardiovascular Risk Consortium (GCVRC) brings together harmonized individual-level data from currently more than 2 million (anticipated: approximately 3 million) individuals across 133 cohorts, 40 countries, and 6 continents, with recruitment ongoing. The GCVRC examines the impact of classical cardiovascular risk factors-such as body-mass index, systolic blood pressure, non-high-density lipoprotein cholesterol, current smoking, and diabetes-on cardiovascular disease (CVD) and death from any cause worldwide. |
| Who can participate | Inclusion Criteria: Population-based individual-level data with available information on the classical cardiovascular risk factors including body-mass index, systolic blood pressure, non-high-density lipoprotein cholesterol, current smoking, and diabetes, as well as the outcomes of interest. Exclusion Criteria: * Participants with age below 18 years * No information on the outcome of interest * No information on the exposure of interest (CVD risk factors) * History of CVD at baseline |
| Ages | 18 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Universitätsklinikum Hamburg-Eppendorf |
| Locations | Hamburg, Free and Hanseatic City of Hamburg, Germany |
| Start date | 2019-09-20 |
| NCT ID | NCT05466825 |
| Official listing | https://clinicaltrials.gov/study/NCT05466825 |